Astera Labs (NASDAQ:ALAB) Shares Climb 1.9% – Time to Buy?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded up 1.9% during trading on Tuesday. The company traded as high as $366.70 and last traded at $357.84. Approximately 2,658,819 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 5,216,984 shares. The stock had previously closed at $351.31.

Wall Street Analyst Weigh In

ALAB has been the subject of a number of research analyst reports. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective for the company in a report on Monday, August 17th. Morgan Stanley raised their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Susquehanna lifted their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Bank of America increased their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $348.33.

Astera Labs Stock Down 0.5%

The company has a 50-day simple moving average of $307.27 and a two-hundred day simple moving average of $279.86. The stock has a market cap of $61.42 billion, a P/E ratio of 175.26 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the firm posted $0.44 earnings per share. The firm’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 396,059 shares of company stock worth $122,605,660. 10.40% of the stock is owned by insiders.

Institutional Trading of Astera Labs

Several institutional investors have recently bought and sold shares of the company. Reflection Asset Management purchased a new stake in shares of Astera Labs during the fourth quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs in the second quarter worth $25,000. Archer Investment Corp bought a new position in shares of Astera Labs during the second quarter valued at $30,000. Whipplewood Advisors LLC boosted its position in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the last quarter. Finally, Transamerica Financial Advisors LLC purchased a new stake in shares of Astera Labs during the second quarter valued at $35,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.